Literature DB >> 8449830

A cancer-reactive human monoclonal antibody derived from a colonic cancer patient treated with local immunotherapy.

T Yagyu1, T Monden, M Baba, Y Tamaki, T Takeda, T Kobayashi, T Shimano, Y Tsuji, H Matsushita, H Osawa.   

Abstract

A human monoclonal antibody, YJ-37 (IgM) was generated through the fusion of human B lymphoblastoid cell line HO-323 with the regional lymph node lymphocytes from a colonic cancer patient who was treated with a local immunotherapy. This antibody was purified and conjugated with biotin, after which direct immunohistochemical staining was performed. The results revealed that YJ-37 selectively reacted with colonic cancer (7/19), gastric cancer (3/6), endometrial cancer (1/2) and colonic adenoma (7/13), but not with normal epithelia. Membrane immunofluorescence and FACS analysis also showed that YJ-37 bound to tumor cell surfaces. Furthermore, the chemical structure of the antigen defined by YJ-37 was analyzed by means of thin-layer chromatography immunostaining and ELISA. The results indicated that YJ-37 reacted with sialylated lacto-series carbohydrate chains, which have been reported to accumulate in cancer cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449830      PMCID: PMC5919026          DOI: 10.1111/j.1349-7006.1993.tb02787.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants.

Authors:  W J Rettig; C Cordon-Cardo; J S Ng; H F Oettgen; L J Old; K O Lloyd
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

2.  Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody.

Authors:  O Nilsson; J E Månsson; L Lindholm; J Holmgren; L Svennerholm
Journal:  FEBS Lett       Date:  1985-03-25       Impact factor: 4.124

3.  Tissue distribution and cellular location of the antigens recognized by human monoclonal antibodies 16.88 and 28A32.

Authors:  J J Starling; R J Cote; P Marder; M J Borowitz; D A Johnson
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

4.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex.

Authors:  M L Phillips; E Nudelman; F C Gaeta; M Perez; A K Singhal; S Hakomori; J C Paulson
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

5.  A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1.

Authors:  R Kannagi; E Nudelman; S B Levery; S Hakomori
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

6.  Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

Authors:  R F Irie; D L Morton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3.

Authors:  R Kannagi; S B Levery; F Ishigami; S Hakomori; L H Shevinsky; B B Knowles; D Solter
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

8.  Human-human hybridomas for the study of anti-tumor immune response in patients with colorectal cancer.

Authors:  P Borup-Christensen; K Erb; J C Jensenius; B Nielsen; S E Svehag
Journal:  Int J Cancer       Date:  1986-05-15       Impact factor: 7.396

9.  Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies.

Authors:  K Koyama; K Akiyama; H Kawahara; A Egashira; H Murakami
Journal:  Jpn J Cancer Res       Date:  1990-10

10.  Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum.

Authors:  Y Tsuji; H Clausen; E Nudelman; T Kaizu; S Hakomori; S Isojima
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  1 in total

1.  Analysis of cytotoxic activity of the CD4+ T lymphocytes generated by local immunotherapy.

Authors:  Y Katsumoto; T Monden; T Takeda; A Haba; Y Ito; E Wakasugi; T Wakasugi; M Sekimoto; T Kobayashi; H Shiozaki; T Shimano; M Monden
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.